U.S. Markets closed

Diversicare Announces 2019 Third Quarter Results

BRENTWOOD, Tenn., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (DVCR), a premier provider of long-term care services, today announced its results for the third quarter ended September 30, 2019.

Third Quarter 2019 Highlights

  • Net loss from continuing operations was $1.9 million, or $0.30 per share, in the third quarter of 2019, compared to net loss from continuing operations of $7.5 million, or $1.17 per share, in the third quarter of 2018.
  • The Company completed its exit from the State of Kentucky effective on August 30, 2019, which consisted of 13 centers and 1,127 skilled nursing beds.
  • Our adjusted EBITDAR for the quarter was $14.4 million.

See below for a reconciliation of all GAAP and non-GAAP financial results.

CEO Remarks

Commenting on the quarter, Jay McKnight, President and Chief Executive Officer, said, "This quarter we successfully completed the exit of operations in the State of Kentucky, which is the latest of our larger initiatives. Over the past year we have undertaken major steps to improve our clinical offerings and risk profile, renew our largest operating lease, improve our operating cost structure, and work through our open government matter.  Our team has been working very hard on these transformative events and I could not be more proud of them.  We continue to explore opportunities to incrementally improve our current portfolio by focusing on improving revenue and the operational efficiency of our business.  As always, I am proud our team’s commitment to our mission of improving every life we touch by providing exceptional healthcare and exceeding expectations."

Third Quarter 2019 Results

The following table summarizes key revenue and census statistics for continuing operations for each period:

  Three Months Ended September 30,
  2019       2018
Skilled nursing occupancy 77.6 %       78.0 %
As a percent of total census:          
Medicare census 8.9 %       10.0 %
Medicaid census 69.9 %       69.3 %
Managed Care census 4.4 %       4.0 %
As a percent of total revenues:          
Medicare revenues 21.5 %       17.1 %
Medicaid revenues 54.9 %       47.0 %
Managed Care revenues 9.2 %       9.4 %
Average rate per day:          
Medicare $ 454.52         $ 447.91  
Medicaid $ 178.35         $ 178.89  
Managed Care $ 389.69         $ 383.87  


Patient Revenues

Patient revenues were $118.6 million and $119.0 million for the three months ended September 30, 2019 and 2018, respectively, a decrease of $0.4 million.

Our Private and Medicare rates for the third quarter of 2019 increased 4.3% and 1.5%, respectively, resulting in revenue increases of $0.4 million and $0.3 million, respectively. Our Hospice, Managed Care, and Medicaid average daily census for the third quarter of 2019 increased 15.1%, 7.9%, and 0.3%, respectively, resulting in $1.1 million, $0.6 million, and $0.2 million in additional revenue, respectively. Conversely, our Medicare and Private average daily census for the third quarter of 2019 decreased 11.6% and 12.5%, respectively, resulting in revenue losses of $2.7 million and $1.1 million, respectively. The Quality Incentive Payment Program ("QIPP") resulted in $0.3 million in additional revenues for the third quarter of 2019 compared to the third quarter of 2018.

Operating Expense

Operating expense decreased in the third quarter of 2019 to $95.6 million from $95.8 million in the third quarter of 2018, a decrease of $0.2 million.  Operating expense increased as a percentage of revenue at 80.6% for the third quarter of 2019 as compared to 80.5% for the third quarter of 2018.

The decrease is mostly attributable to decreases in nursing and ancillary expenses and workers compensation costs of $0.8 million and $0.5 million, respectively, in the third quarter of 2019 compared to the third quarter of 2018. This was partially offset by increases in health insurance costs and general insurance costs of $0.7 million and $0.2 million, respectively, in the third quarter of 2019 compared to the third quarter of 2018.

One of the largest components of operating expenses is wages, which remained consistent at $58.2 million in the third quarter of 2018 and 2019.

Lease expense in the third quarter of 2019 increased to $13.3 million as compared to $12.1 million in the third quarter of 2018.  The increase in lease expense was due to rent increases resulting from the new master lease agreement with Omega Healthcare Investors and the $1.1 million impact of non-cash straight-line rent expense.

Professional liability expense was $1.7 million and $1.6 million in the third quarters of 2019 and 2018, respectively. Our cash expenditures for professional liability costs of continuing operations were $1.5 million for the third quarters of 2019 and 2018. Professional liability expense fluctuates based on the results of our third-party professional liability actuarial studies, premiums and cash expenditures are incurred to defend and settle existing claims.

In the third quarter of 2018, the Company recorded $6.4 million in litigation contingency expense. In June, 2019, the Company and the U.S. Department of Justice reached an agreement in principle on the financial terms of a settlement regarding a civil investigative demand in the amount of $9.5 million, and recorded an additional $3.1 million in litigation contingency expense. The Company denies any wrong doing and is prepared to vigorously defend its actions.

General and administrative expense was $6.9 million for the third quarters of both 2019 and 2018. General and administrative expense remained consistent as a percentage of revenue at 5.8% in the third quarter of 2019 and 2018.

Depreciation and amortization expense was $2.3 million in the third quarter of 2019 as compared to $2.7 million in the third quarter of 2018. Decrease in depreciation expense relates to the decrease in capital expenditures.

Interest expense was $1.6 million in the third quarter of 2019 and $1.4 million in the third quarter of 2018. The increase of $0.2 million is due to an increase in the outstanding borrowings on our loan facilities.

The Company recorded an income tax benefit of $0.7 million during the third quarter of 2019 and $0.3 million during the third quarter of 2018.

As a result of the above, continuing operations reported a loss of $2.7 million before income taxes for the third quarter of 2019 as compared to a loss of $7.7 million for the third quarter of 2018. Both basic and diluted loss per common share from continuing operations were $0.30 for the third quarter of 2019 as compared to both basic and diluted loss per common share from continuing operations of $1.17 in the third quarter of 2018.

Receivables

Our net receivables balance decreased $4.3 million to $62.0 million as of September 30, 2019, from $66.3 million as of December 31, 2018.

Conference Call Information

A conference call has been scheduled for Thursday, October 31, 2019 at 4:00 P.M. Central time (5:00 P.M. Eastern time) to discuss third quarter 2019 results.  The conference call information is as follows:

     
Date:   Thursday, October 31, 2019
Time:   4:00 P.M. Central, 5:00 P.M. Eastern
Webcast Links:   www.DVCR.com
Dial in numbers:   877.340.2552 (domestic) or 253.237.1159 (International)
Conference ID: 8375927
The Operator will connect you to Diversicare’s Conference Call

A replay of the conference call will be accessible two hours after its completion through November 7, 2019, by dialing 855-859-2056 (domestic) or 404-537-3406 (international) and entering Conference ID 8375927.

FORWARD-LOOKING STATEMENTS

The “forward-looking statements” contained in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend,” and similar words indicating possible future expectations, events or actions. These forward-looking statements reflect our current views with respect to future events and present our estimates and assumptions only as of the date of this release. Actual results could differ materially from those contemplated by the forward-looking statements made in this release. In addition to any assumptions and other factors referred to specifically in connection with such statements, other factors, many of which are beyond our ability to control or predict, could cause our actual results to differ materially from the results expressed or implied in any forward-looking statements including, but not limited to, our ability to successfully integrate the operations of our new nursing centers, as well as successfully operate all of our centers, our ability to increase census and occupancy rates at our centers, changes in governmental reimbursement, government regulation, the impact of the recently adopted federal health care reform or any future health care reform, any increases in the cost of borrowing under our credit agreements, our ability to comply with covenants contained in those credit agreements, our ability to comply with the terms of our master lease agreements, our ability to renew or extend our leases at or prior to the end of the existing lease terms, the outcome of professional liability lawsuits and claims, our ability to control ultimate professional liability costs, the accuracy of our estimate of our anticipated professional liability expense, the impact of future licensing surveys, the outcome of proceedings alleging violations of state or Federal False Claims Acts, laws and regulations governing quality of care or other laws and regulations applicable to our business including HIPAA and laws governing reimbursement from government payors, the costs of investing in our business initiatives and development, our ability to control costs, our ability to attract and retain qualified healthcare professionals, changes to our valuation of deferred tax assets, changing economic and competitive conditions, changes in anticipated revenue and cost growth, changes in the anticipated results of operations, the effect of changes in accounting policies as well as others. The Company has provided additional information in its Annual Report on Form 10-K for the fiscal year ended December 31, 2018, as well as in its other filings with the Securities and Exchange Commission, which readers are encouraged to review for further disclosure of other factors. These assumptions may not materialize to the extent assumed, and risks and uncertainties may cause actual results to be different from anticipated results. These risks and uncertainties also may result in changes to the Company’s business plans and prospects. Diversicare Healthcare Services, Inc. is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

Diversicare provides long-term care services to patients in 62 nursing centers and 7,329 skilled nursing beds. For additional information about the Company, visit Diversicare's web site: www.DVCR.com.

-Financial Tables to Follow-


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

    September 30,
 2019
  December 31,
 2018
    (Unaudited)    
ASSETS:        
Current Assets        
Cash and cash equivalents   $ 3,940     $ 2,685  
Receivables   62,036     66,257  
Self-insurance receivables, current portion   1,672     4,475  
Current assets of discontinued operations       155  
Other current assets   6,905     6,965  
     Total current assets   74,553     80,537  
         
Property and equipment, net   48,448     50,843  
Deferred income taxes, net       15,851  
Acquired leasehold interest, net   5,869     6,307  
Operating lease assets   316,626      
Other assets   3,644     3,450  
Noncurrent assets of discontinued operations       2,256  
TOTAL ASSETS   $ 449,140     $ 159,244  
         
LIABILITIES AND SHAREHOLDERS' DEFICIT:        
Current Liabilities        
Current portion of long-term debt and finance lease
obligations, net
  $ 12,333     $ 12,449  
Trade accounts payable   14,401     15,659  
Current liabilities of discontinued operations       86  
Current portion of operating lease liabilities   22,986      
Accrued expenses:        
     Payroll and employee benefits   16,969     19,471  
     Current portion of self-insurance reserves   12,235     13,158  
     Other current liabilities   11,468     9,522  
     Total current liabilities   90,392     70,345  
Noncurrent Liabilities        
Long-term debt and finance lease obligations, less current
portion and deferred financing costs, net
  63,167     60,984  
Operating lease liabilities, less current portion   301,905      
Self-insurance reserves, less current portion   17,007     16,057  
Accrued litigation contingency, less current portion    9,000     6,400  
Other noncurrent liabilities   1,497     6,656  
     Total noncurrent liabilities   392,576     90,097  
         
SHAREHOLDERS’ DEFICIT   (33,828 )   (1,198 )
         
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT   $ 449,140     $ 159,244  
         


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
 INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

  Three Months Ended
September 30,
  2019   2018
PATIENT REVENUES, net $ 118,630     $ 119,035  
Operating expense 95,591     95,768  
Facility-level operating income 23,039     23,267  
       
EXPENSES:      
Lease and rent expense 13,251     12,060  
Professional liability 1,737     1,604  
Litigation contingency expense      6,400  
General and administrative 6,902     6,873  
Depreciation and amortization 2,279     2,662  
     Total expenses less operating 24,169     29,599  
OPERATING LOSS (1,130 )   (6,332 )
OTHER INCOME (EXPENSE):      
Interest expense, net (1,554 )   (1,382 )
Other income 25      
     Total other expense
(1,529 )   (1,382 )
           
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (2,659 )   (7,714 )
BENEFIT FOR INCOME TAXES  741     252  
LOSS FROM CONTINUING OPERATIONS (1,918 )   (7,462 )
INCOME (LOSS) FROM DISCONTINUED OPERATIONS (2,956 )   65  
NET LOSS $ (4,874 )   $ (7,397 )
       
NET LOSS PER COMMON SHARE:      
Per common share – basic      
     Continuing operations $ (0.30 )   $ (1.17 )
     Discontinued operations (0.45 )   0.01  
  $ (0.75 )   $ (1.16 )
Per common share – diluted      
     Continuing operations $ (0.30 )   $ (1.17 )
     Discontinued operations (0.45 )   0.01  
  $ (0.75 )   $ (1.16 )
       
DIVIDENDS DECLARED PER SHARE OF COMMON STOCK $     $ 0.055  
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:      
     Basic 6,470     6,400  
     Diluted 6,470     6,400  


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
 INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

  Nine Months Ended September 30,
  2019   2018
PATIENT REVENUES, net $ 354,145     $ 357,406  
Operating expense 284,643     284,823  
Facility-level operating income 69,502     72,583  
       
EXPENSES:      
Lease and rent expense 39,480     36,105  
Professional liability 5,182     4,898  
Litigation contingency expense 3,100     6,400  
General and administrative 21,267     23,046  
Depreciation and amortization 6,812     7,686  
      Total expenses less operating 75,841     78,135  
OPERATING LOSS (6,339 )   (5,552 )
OTHER INCOME (EXPENSE):      
Gain on sale of investment in unconsolidated affiliate     308  
Interest expense, net (4,424 )   (4,147 )
Other income 207     113  
     Total other expense (4,217 )   (3,726 )
           
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (10,556 )   (9,278 )
BENEFIT (PROVISION) FOR INCOME TAXES  (15,544 )   903  
LOSS FROM CONTINUING OPERATIONS (26,100 )   (8,375 )
INCOME (LOSS) FROM DISCONTINUED OPERATIONS (6,716 )   564  
NET LOSS $ (32,816 )   $ (7,811 )
       
NET LOSS PER COMMON SHARE:      
Per common share – basic      
     Continuing operations $ (4.04 )   $ (1.32 )
     Discontinued operations (1.04 )   0.09  
  $ (5.08 )   $ (1.23 )
Per common share – diluted      
     Continuing operations $ (4.04 )   $ (1.32 )
     Discontinued operations (1.04 )   0.09  
  $ (5.08 )   $ (1.23 )
       
DIVIDENDS DECLARED PER SHARE OF COMMON STOCK $     $ 0.17  
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:      
     Basic 6,455     6,362  
     Diluted 6,455     6,362  


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

  Nine Months Ended September 30,
  2019   2018
NET LOSS $ (32,816 )   $ (7,811 )
Discontinued operations (6,716 )   564  
Net loss from continuing operations (26,100 )   (8,375 )
Adjustments to reconcile net loss from continuing operations to cash
provided by (used in) operating activities:
     
Depreciation and amortization 6,812     7,686  
Deferred income tax provision (benefit) 15,851     (829 )
Provision for self-insured professional liability, net of cash payments 4,682     2,224  
Stock based compensation 429     947  
Provision for leases, net of cash payments 3,768     (1,363 )
Litigation contingency expense 3,100     6,400  
Gain on sale of unconsolidated affiliate     (308 )
Other 643     251  
Changes in other assets and liabilities (498 )   (2,122 )
Cash provided by operating activities from continuing operations 8,687     4,511  
Cash provided by (used in) operating activities from discontinued operations (5,130 )   1,153  
Cash provided by operating activities 3,557     5,664  
       
Cash used in investing activities from continuing operations (3,745 )   (4,381 )
Cash provided by (used in) investing activities from discontinued operations 6     (1,275 )
Cash used in investing activities (3,739 )   (5,656 )
       
Cash provided by (used in) financing activities 1,437     (44 )
       
Net increase in cash 1,255     (36 )
Cash beginning of period 2,685     3,524  
Cash end of period $ 3,940     $ 3,488  


DIVERSICARE HEALTHCARE SERVICES, INC.
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA, ADJUSTED EBITDA AND ADJUSTED EBITDAR
(In thousands)

    For Three Months Ended
    September 30,
2019
  June 30,
2019
  March 31,
2019
  December 31,
2018
  September 30,
2018
    (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited)
Net income (loss)   $ (4,874 )   $ (24,596 )   $ (3,346 )   $ 415     $ (7,397 )
(Income) loss from discontinued
operations, net of tax
  2,956     1,981     1,781     (3,109 )   65  
Income tax provision (benefit)   (741 )   17,312     (1,028 )   (774 )   (169 )
Interest expense   1,554     1,477     1,394     1,386     1,382  
Depreciation and amortization   2,279     2,217     2,316     2,304     2,662  
Debt retirement costs (a)               267      
EBITDA   1,174     (1,609 )   1,117     489     (3,457 )
                     
EBITDA adjustments:                    
Litigation contingency expense (b)       3,100             6,400  
Severance expense (c)       87         157      
Adjusted EBITDA   $ 1,174     $ 1,578     $ 1,117     $ 646     $ 2,943  
                     
Lease expense (d)   $ 13,251     $ 13,114     $ 13,115     $ 13,126     $ 12,060  


(a) Represents non-recurring debt retirement costs related to the amendment of our debt agreements in December 2018.
(b) Represents non-recurring expected costs associated with the DOJ investigation.
(c) Represents non-recurring costs associated with severance expenses. 
(d) As management, we evaluate Adjusted EBITDA exclusive of lease expense, or Adjusted EBITDAR, as a financial valuation metric. For the three month period ended September 30, 2019, Adjusted EBITDAR is calculated below.


                            Adjusted EBITDA $ 1,174  
  Lease expense 13,251  
  Adjusted EBITDAR $ 14,425  


DIVERSICARE HEALTHCARE SERVICES, INC.
RECONCILIATION OF NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE
SERVICES, INC. COMMON SHAREHOLDERS TO ADJUSTED NET INCOME (LOSS)
FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS
 (In thousands, except per share data)

    For Three Months Ended
    September 30,
2019
  June 30,
2019
  March 31,
2019
  December 31,
2018
  September 30,
2018
    (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited)
Net income (loss)   $ (4,874 )   $ (24,596 )   $ (3,346 )   $ 415     $ (7,397 )
Adjustments:                    
Litigation contingency expense (a)       3,100             6,400  
Severance expense (b)       87         157      
Debt retirement costs (c)               267      
Tax impact of above adjustments (d)       (40 )       (486 )    
Discontinued operations, net of tax   2,956     1,981     1,781     (3,109 )   65  
Adjusted net loss   $ (1,918 )   $ (19,468 )   $ (1,565 )   $ (2,756 )   $ (932 )
                     
Adjusted net income (loss) per common share                    
Basic   $ (0.30 )   $ (3.01 )   $ (0.24 )   $ (0.43 )   $ (0.15 )
Diluted   $ (0.30 )   $ (3.01 )   $ (0.24 )   $ (0.43 )   $ (0.15 )
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                    
Basic   6,470     6,472     6,424     6,402     6,400  
Diluted   6,470     6,472     6,424     6,402     6,400  
                     


(a) Represents non-recurring expected costs associated with the DOJ investigation.
(b) Represents non-recurring costs associated with severance expenses. 
(c) Represents non-recurring debt retirement costs related to the amendment of our debt agreements in December 2018. 
(d) Represents tax provision for the cumulative adjustments for each period.

We have included certain financial performance and valuation measures in this press release, including EBITDA, Adjusted EBITDA, Adjusted EBITDAR, and Adjusted Net income (loss), which are “non-GAAP financial measures” using accounting principles generally accepted in the United States (GAAP) and using adjustments to GAAP (non-GAAP). These non-GAAP measures are not measurements under GAAP. These measurements should be considered in addition to, but not as a substitute for, the information contained in our financial statements prepared in accordance with GAAP. We define EBITDA as net income (loss) adjusted for loss (income) from discontinued operations, interest expense, debt retirement costs, income tax and depreciation and amortization. We define Adjusted EBITDA as EBITDA adjusted for litigation contingency expense and severance expense. We define Adjusted EBITDAR as Adjusted EBITDA adjusted for rent expense. We define Adjusted Net income (loss) as Net income (loss) adjusted for debt retirement costs, litigation contingency expense, severance expense and income (loss) from discontinued operations.

Our measurements of EBITDA, Adjusted EBITDA, Adjusted EBITDAR, and Adjusted Net income (loss) may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA, Adjusted EBITDA, and Adjusted Net income (loss) in this press release because we believe that such information is used by certain investors as measures of the Company’s historical performance. Management believes that Adjusted EBITDA, and Adjusted Net income (loss) are important financial performance measurements because they eliminate certain nonrecurring start-up losses and separation costs. Our presentation of EBITDA, Adjusted EBITDA, and Adjusted Net income (loss) should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

We have included Adjusted EBITDAR in this press release because we believe that such information is used by certain investors as measures of the Company’s valuation. We believe that Adjusted EBITDAR is an important financial valuation measure that is commonly used by our management, research analysts, investors, lenders and financial institutions, to compare the enterprise value of different companies in the healthcare industry, without regard to differences in capital structures and leasing arrangements. Adjusted EBITDAR is a financial valuation measure and is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. As such, our presentation of Adjusted EBITDAR, should not be construed as a financial performance measure.


DIVERSICARE HEALTHCARE SERVICES, INC.
SELECTED OPERATING STATISTICS

(Unaudited)
Three Months Ended September 30, 2019
        As of September 30,
2019
     
 
 Occupancy (Note 2)                
Region
(Note 1)
  Licensed
Nursing
Beds
Note (4)
  Available
Nursing
Beds
Note (4)
  Skilled Nursing
Weighted
Average Daily
Census
  Licensed
Nursing
Beds
  Available
Nursing
Beds
  Medicare
 Utilization
2019 Q3
 Revenue
($ in millions)
  Medicare
Room and
Board
Revenue PPD
(Note 3)
  Medicaid
Room and
Board Revenue
PPD
(Note 3)
Alabama   2,464     2,397     2,148     87.2 %   89.6 %   8.3 %   $ 45.3     $ 438.29     $ 188.07  
Kansas   464     464     382     82.4 %   82.4 %   9.7 %   7.7     439.13     175.05  
Mississippi   1,039     1,004     880     84.7 %   87.7 %   11.8 %   18.8     427.58     189.74  
Missouri   339     339     216     63.7 %   63.7 %   6.7 %   3.8     475.27     143.95  
Ohio   561     551     446     79.5 %   80.9 %   12.1 %   12.4     477.57     197.64  
Tennessee   617     551     437     70.8 %   79.3 %   12.6 %   9.9     450.30     202.54  
Texas   1,845     1,662     1,176     63.7 %   70.7 %   5.2 %   20.8     535.04     146.19  
Total   7,329     6,968     5,685     77.6 %   81.6 %   8.9 %   $ 118.7     $ 454.52     $ 178.35  
                                     
  Note 1: The Alabama region includes nursing centers in Alabama and Florida. The Ohio region includes one nursing center in Indiana.
  Note 2: The number of Licensed Nursing Beds is based on the licensed capacity of the facility. The Company has historically reported its occupancy based on licensed nursing beds, and excludes a limited number of assisted living, independent living, and personal care beds. The number of Available Nursing Beds represents licensed nursing beds less beds removed from service. Available nursing beds is subject to change based upon the needs of the facilities, including configuration of patient rooms, common usage areas and offices, status of beds (private, semi-private, ward, etc.) and renovations. Occupancy is measured on a weighted average basis.
  Note 3: These Medicare and Medicaid revenue rates include room and board revenues, but do not include any ancillary revenues related to these patients.
  Note 4: The Licensed and Available Nursing Bed counts above include only licensed and available SNF beds.


Company Contact:
James R. McKnight, Jr.
Chief Executive Officer
615-771-7575
    Investor Relations:
  Kerry D. Massey
  Chief Financial Officer
  615-771-7575